whi p154 has been researched along with Arthritis, Rheumatoid in 1 studies
WHI P154: an anti-leukemic agent; structure in first source
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Changelian, PS | 1 |
| Moshinsky, D | 1 |
| Kuhn, CF | 1 |
| Flanagan, ME | 1 |
| Munchhof, MJ | 1 |
| Harris, TM | 1 |
| Whipple, DA | 1 |
| Doty, JL | 1 |
| Sun, J | 1 |
| Kent, CR | 1 |
| Magnuson, KS | 1 |
| Perregaux, DG | 1 |
| Sawyer, PS | 1 |
| Kudlacz, EM | 1 |
1 other study available for whi p154 and Arthritis, Rheumatoid
| Article | Year |
|---|---|
The specificity of JAK3 kinase inhibitors.
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Enzyme Inhibitors; Graft Rejection; Humans; Janus K | 2008 |